Stay updated with breaking news from Michael Platten. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
All patients in a rectal cancer drug trial were in remission after six months. Experts say it's 'revolutionary' but bigger, more diverse studies are needed.
Escape the hustle and bustle of the coast, and retreat inland this summer to one of these luxurious hotels, glamping sites or camping pitches
Escape the hustle and bustle of the coast, and retreat inland this summer to one of these luxurious hotels, glamping sites or camping pitches
Brain tumor cells with a certain common mutation reprogram invading immune cells. This leads to the paralysis of the body's immune defense against the tumor in the brain. Researchers from Heidelberg, Mannheim, and Freiburg discovered this mechanism and at the same time identified a way of reactivating the paralyzed immune system to fight the tumor. These results confirm that therapeutic vaccines or immunotherapies are more effective against brain tumors if active substances are simultaneously used to promote the suppressed immune system.
Researchers from Heidelberg have carried out a clinical trial to test a mutation-specific vaccine against malignant brain tumors.